SeraNovo's Eutectic Formulation Exceeds ASD by 75% in Bioavailability


Insights from the Case Study of Atazanavir

Our formulation has achieved an impressive 75% higher bioavailability compared to traditional formulations. Download the full PDF to uncover the science behind our innovative formulation strategy.